"Illumina/TruSight Tumor 15 (Library Prep Only)/OP-101-1002/1 Ea

" OP-101-1002 Illumina 產(chǎn)品編號(hào)： OP-101-1002美  元  價(jià)： $0.00會(huì)  員  價(jià)： 待定品       牌： Illumina產(chǎn)       地： 美國公       司： Illumina, Inc.產(chǎn)品分類： 其它>其它試劑>芯片公司分類： Clinical Research Products "Product Highlights:

TruSight Tumor 15 uses next-generation sequencing (NGS) technology to provide a comprehensive assessment of 15 genes that are commonly mutated in solid tumors. It accurately detects low-frequency variants from 20 ng of starting DNA and is optimized for formalin-fixed, paraffin-embedded (FFPE) tumor tissue.

View the Gene List

Featuring a rapid workflow that can be easily integrated into lab procedures, this panel offers a single assay for accurate, economical, and rapid analysis of solid tumors.

This TruSight Tumor panel offers:

Comprehensive workflow: Assess 15 genes with one simple workflow instead of single, iterative gene testing with polymerase chain reaction (PCR)

Efficient: Rapid turnaround with only 3.5 hours of hands-on time, going from DNA to data in approximately 36 hours

Relevant gene content for solid tumors: Somatic variants selected from relevant industry guidelines1,2, key opinion leaders3,4, and pharmaceutical research

Sensitive variant detection from low DNA input: Accurate somatic variant detection of 5% allele frequency using 20 ng DNA from FFPE tissue samples

TruSight Tumor 15 Sample Datasets

3 human reference samples and 5 FFPE-exacted DNA samples from lung, colon, melanoma, and breast tumors were prepared using TruSight Tumor 15. These libraries were sequenced on the MiniSeq System using a high output kit at a 2 x 150 bp read length configuration with dual indexing. The total yield was 7.6 Gb with 94.9% of bases at or above Q30.

Browse the data in BaseSpace Sequence Hub:

View Run

View Project

Access to this data requires a BaseSpace Sequence Hub login.

Register for BaseSpace Sequence Hub

Specifications:

Assay Time 7 hours

Hands-On Time 3.5 hours

Input Quantity 20 ng

System Compatibility MiSeq,MiSeqDx in Research Mode,MiniSeq

Specialized Sample Types FFPE,Low Input

Technology Sequencing

Variant Class Somatic Variants,Insertions-Deletions (indels)

Species Category Human

Cancer Type Solid Tumor

Method Amplicon Sequencing,Targeted DNA Sequencing

"

Illumina公司，致力于新一代測(cè)序和芯片技術(shù)的生產(chǎn)與開發(fā)，提供產(chǎn)品與應(yīng)用資訊

Illumina公司創(chuàng)立于1998年4月，是遺傳變異和生物學(xué)功能分析領(lǐng)域的優(yōu)秀的產(chǎn)品、技術(shù)和服務(wù)供應(yīng)商。通過幫助客戶加快實(shí)現(xiàn)生物信息的采集、分析和應(yīng)用，來改善人類健康。

Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products

Illumina公司基因芯片、二代測(cè)序NGS測(cè)序儀及相關(guān)測(cè)序試劑盒等產(chǎn)品

咨詢illumina MiSeq測(cè)序試劑盒等產(chǎn)品歡迎您致電 上海易匯生物科技有限公司：1850 1609 238張經(jīng)理